Go to Page # Page of 23

Bioanalytical Method Validation of the CK18 Apoptosis Biomarker for NASH Drug Development

 Sumit Kar
  13th-Sep-2018
Description: Bioanalytical Method Validation of the CK18 Apoptosis Biomarker for NASH Drug Development.
Views: 804
Domain: Medical
Category: Biotech/Pharma
Contributing Organization: VIROLOGY EDUCATION
 ‐ More of their Presentations
Contents:
A Context of Use Framework for Bioanalytical
Method Validation of the CK18 Apoptosis
Biomarker for NASH Drug Development
Sumit Kar
Lead Scientist, Biomarkers
NASH Biomarkers Workshop 2018

NASH and Soluble Biomarkers
▪ “Liquid biopsy”
▪ Pathophysiological concentrations of
hormones, cytokines or metabolites
related to fatty liver disease

▪ Clinical biomarkers
... See more

Recent Presentations

...
20 September, 2018
...
19 September, 2018
...
18 September, 2018